From GlobeNewswire: 2024-06-13 14:00:00

The Global Specimen Collection Cards Market is projected to grow from USD 426.02 million in 2023 to USD 701.02 million by 2033, with a CAGR of 5.11%. Rising prevalence of infectious diseases drives the need for diagnostic equipment, with the cotton & cellulose-based segment leading in revenue. Blood specimens are crucial for diagnostics, with hospitals & clinics being major end users. North America dominates the market, while the Asia-Pacific region is expected to accelerate. Major vendors include PerkinElmer Inc., Danaher Corporation, and QIAGEN. Recent developments include the efficacy of Whatman FTA cards in molecular diagnostics for Yellow Fever Virus identification. Market segments include product type, specimen, and end user, with regional analysis covering North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Other related reports cover Life Science Reagents, Multiplex Assay, Sterile Filtration, and Viral Vector And Plasmid DNA Testing Services markets. Spherical Insights & Consulting offers market research and consulting services for decision makers.



Read more at GlobeNewswire: Global Specimen Collection Cards Market Size To Exceed USD